Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey
- PMID: 15120733
- DOI: 10.1016/j.ijantimicag.2003.09.029
Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey
Erratum in
- Int J Antimicrob Agents. 2005 Jan;25(1):93
Abstract
The aim of this study was to determine the in vitro antimicrobial activity of recently licensed quinupristin/dalfopristin and linezolid which have not yet been in clinical use in Turkey against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) strains isolated from various clinical specimens by using the Etest. The results showed that all MRSA strains were fully susceptible to both the new compounds. All strains were inhibited by 1 mg/l quinupristin/dalfopristin (mode MIC 0.38 mg/l) and by 3 mg/l linezolid (mode MIC 1.5 mg/l). Four strains of Enterococcus faecium showed an increase of resistance of 2-3 mg/l to quinupristin/dalfopristin (susceptible mode MIC 0.38 mg/l). With linezolid, all strains except two fell within the range 0.75-2.0 mg/l.
Similar articles
-
In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.Indian J Med Res. 2004 Dec;120(6):546-52. Indian J Med Res. 2004. PMID: 15654141
-
A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.Clin Microbiol Infect. 2008 Jun;14(6):608-11. doi: 10.1111/j.1469-0691.2008.01993.x. Epub 2008 Apr 5. Clin Microbiol Infect. 2008. PMID: 18397336
-
Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.Scand J Infect Dis. 2007;39(11-12):1059-62. doi: 10.1080/00365540701466231. Epub 2007 Jul 30. Scand J Infect Dis. 2007. PMID: 17852934
-
In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.Int J Antimicrob Agents. 2006 Nov;28(5):385-8. doi: 10.1016/j.ijantimicag.2006.07.017. Int J Antimicrob Agents. 2006. PMID: 17046205 Review.
-
Treatment options for vancomycin-resistant enterococcal infections.Drugs. 2002;62(3):425-41. doi: 10.2165/00003495-200262030-00002. Drugs. 2002. PMID: 11827558 Review.
Cited by
-
Solid-state NMR characterization of amphomycin effects on peptidoglycan and wall teichoic acid biosyntheses in Staphylococcus aureus.Sci Rep. 2016 Aug 19;6:31757. doi: 10.1038/srep31757. Sci Rep. 2016. PMID: 27538449 Free PMC article.
-
The effects of daptomycin on cell wall biosynthesis in Enterococcal faecalis.Sci Rep. 2023 Jul 28;13(1):12227. doi: 10.1038/s41598-023-39486-8. Sci Rep. 2023. PMID: 37507537 Free PMC article.
-
Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis.J Clin Microbiol. 2006 May;44(5):1915-6. doi: 10.1128/JCM.44.5.1915-1916.2006. J Clin Microbiol. 2006. PMID: 16672440 Free PMC article.
-
Evaluation of Antimicrobial Resistance in Staphylococcus aureus Isolates by Years.Interdiscip Perspect Infect Dis. 2016;2016:9171395. doi: 10.1155/2016/9171395. Epub 2016 May 9. Interdiscip Perspect Infect Dis. 2016. PMID: 27247572 Free PMC article.
-
Antibiotic Resistance and Molecular Epidemiology of Vancomycin-Resistant Enterococci in a Tertiary Care Hospital in Turkey.Infect Drug Resist. 2020 Jan 21;13:191-198. doi: 10.2147/IDR.S191881. eCollection 2020. Infect Drug Resist. 2020. PMID: 32021333 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
